Cargando…
Development and evaluation of febuxostat solid dispersion through screening method
Febuxostat (Febux) is a BCS II drug and has a very low solubility. In order to overcome this shortcoming, the purpose of study is to increase the in vitro dissolution (%) and drug release (%) of Febux by using a screening method. The Febux-SD formulation was prepared by screening solubilizers, pH ag...
Autores principales: | Sohn, Jeong Sun, Choi, Jin-Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406859/ https://www.ncbi.nlm.nih.gov/pubmed/37559865 http://dx.doi.org/10.1016/j.jsps.2023.101724 |
Ejemplares similares
-
Development and evaluation of solid dispersion of spironolactone using fusion method
por: Shamsuddin,, et al.
Publicado: (2016) -
Evaluation of Pharmacokinetic Feasibility of Febuxostat/L-pyroglutamic Acid Cocrystals in Rats and Mice
por: Yu, Jeong-Eun, et al.
Publicado: (2023) -
Development and evaluation of niacinamide transdermal formulation by artificial membrane permeability
por: Sohn, Jeong Sun, et al.
Publicado: (2023) -
Febuxostat methanol solvate
por: Jiang, Qi-Ying, et al.
Publicado: (2011) -
Febuxostat ethanol monosolvate
por: Gelbrich, Thomas, et al.
Publicado: (2020)